In summary, our findings suggest that resveratrol diminishes inflammation and fibrosis in rheumatoid arthritis-associated interstitial lung disease by reinstating autophagic lysosomal flux through the AKT/TMEM175 pathway. The gene discussed is AKT1; the disease is interstitial lung disease.